Position in NVS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$7,784,282
+$195,051 QoQ
Shares Held
49,670
-0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#201
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cardinal Capital Management holds $99,250,544 across 9 Drug Manufacturers - General names. NVS ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,505 | $31,790,894 | |
| 2 | JNJ |
Johnson & Johnson
|
114,813 | $29,159,057 | |
| 3 | MRK |
Merck & Co., Inc.
|
96,235 | $12,366,197 | |
| 4 | NVS |
Novartis AG
This page
|
49,670 | $7,784,282 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,075 | $6,054,421 | |
| 6 | SNY |
Sanofi
|
80,450 | $3,431,997 | |
| 7 | GSK |
GSK plc
|
62,101 | $3,255,334 | |
| 8 | PFE |
Pfizer Inc
|
124,537 | $2,998,850 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,784,282 | 49,670 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $7,589,231 | 49,684 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $6,847,313 | 49,665 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $6,355,702 | 49,561 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $5,931,063 | 49,013 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $5,345,577 | 47,951 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $4,652,293 | 47,809 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,442,631 | 47,319 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $4,990,312 | 46,875 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $4,422,398 | 45,719 | Shares | Sole | 2024-07-12 | |
| 2023-12-31 | $4,225,493 | 41,849 | Shares | Sole | 2024-07-12 | |
| 2023-09-30 | $4,247,052 | 41,695 | Shares | Sole | 2024-07-12 | |
| 2023-06-30 | $4,125,099 | 40,879 | Shares | Sole | 2024-07-12 | |
| 2023-03-31 | $3,812,756 | 41,443 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $3,768,780 | 41,543 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,180,258 | 41,840 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,582,888 | 42,386 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,697,434 | 42,136 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,544,371 | 40,521 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,299,986 | 40,352 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $3,669,034 | 40,213 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,397,573 | 39,747 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $3,678,803 | 38,958 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $3,317,350 | 38,148 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $3,305,731 | 37,849 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $3,574,372 | 43,352 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||